Fundraising Fox

Biomotum

Portland, US · Founded 2019 · Delaware corporation · 3 known investors

Find your way into Biomotum

352 people in our graph share verified history with the Biomotum team — schools, employers, funds. One of them is your warm intro.

Chris Rustunlockedknows Ray Browning · together at University of Colorado Boulder (overlapped)
×5knows the team · via UCLA
×5knows the team · via Nike
knows the team · via University of Colorado Boulder

Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.

Founders & leadership

Biomotum was founded in 2019 by Ray Browning and Zach Lerner.

RBRay Browning
Ray BrowninginCEO & Co FounderRay Browning founded Biomotum, a company developing wearable robotic systems for gait rehabilitation. He has background in research and product development across industry and academic settings, with expertise in engineering, human performance, and clinical science.
ZLZach Lerner
Zach LernerinCTO & Co FounderAn associate professor of mechanical engineering at Northern Arizona University, where he has held the position since 2022. He completed his PhD at Colorado State University and was a postdoctoral researcher at the National Institutes of Health.

Investors · 3

Reported raises · per SEC filings

Form D private placements

$860K disclosed across 2 rounds · 2020–2022

$200KraisedMar 2022 · 2 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Zachary L. LernerExecutive Officer, Director
  • Raymond C. BrowningExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$200K
First sale
Mar 2022
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$660KraisedNov 2020 · 3 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • RAYMOND C BROWNINGExecutive Officer, Director, Promoter
  • ZACHARY L LERNERExecutive Officer, Director, Promoter
Offering amount
$1M
Amount sold
$660K
Minimum investment
$25K
First sale
Oct 2020
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 7

by search overlap
Bioptimus8 shared keywordsBioptimus is an AI-first biotech company developing a universal AI foundation model that connects biology across scales, from molecules and cells to tissues and whole organisms, to support biomedical research and innovation. It applies machine learning to areas such as computational pathology, genomics, and drug discovery.
Ekso Bionics7 shared keywordsEkso Bionics develops wearable exoskeleton robotics used to help people with paralysis stand and walk, to augment worker physical capabilities, and to support rehabilitation and R&D. It serves medical/rehabilitation and industrial markets in the healthcare robotics and medical device category.
Hypershell Global5 shared keywordsHypershell builds wearable exoskeletons that assist walking, hiking, climbing, and cycling by reducing physical exertion and heart rate over long distances and steep terrain. Its products target outdoor adventurers, hikers, and expedition guides, and it is presented as the first exoskeleton to undergo third-party validation of its performance claims.
bio5 shared keywordsBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
German Bionic5 shared keywordsGerman Bionic develops wearable exoskeletons and smart power suits that use AI to assist workers with heavy lifting, prevent posture injuries, and improve workplace safety. The company serves industrial, logistics, healthcare, and airport operations sectors globally.
Bioventus4 shared keywordsBioventus develops and markets medical devices for active healing, including pain management, restorative therapies, and surgical solutions that aim to enhance the body's natural healing processes and reduce the need for invasive procedures. The company serves healthcare providers and patients seeking clinically effective, cost-efficient alternatives to traditional treatments.
Mammoth Biosciences4 shared keywordsMammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.

Companies competing with Biomotum for the same Google search keywords, organic and paid, via search-intersection analysis.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2023$274.3K
National Institutes of Health (NIH)National Institutes of HealthPhase II2021$1.7M
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$298.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Biomotum do?
Biomotum develops wearable robotic systems for gait rehabilitation that assist individuals with neurological impairments such as cerebral palsy and stroke. The technology is designed for clinical use and aims to improve walking function and patient mobility outcomes.
Who founded Biomotum?
Biomotum was founded by Ray Browning, Zach Lerner in 2019.
Who are Biomotum's investors?
Biomotum's investors include Creative Destruction Lab (CDL), Elevate Capital, Portland Seed Fund.
How much funding has Biomotum raised?
Biomotum has disclosed $860K raised across 2 rounds.
Where is Biomotum headquartered?
Biomotum is headquartered in Portland, US.